Cited 12 times in
Effects of anti-resorptive drugs on implant survival and peri-implantitis in patients with existing osseointegrated dental implants: a retrospective cohort study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박진후 | - |
dc.contributor.author | 김준영 | - |
dc.contributor.author | 정영수 | - |
dc.contributor.author | 정휘동 | - |
dc.date.accessioned | 2020-09-28T11:41:26Z | - |
dc.date.available | 2020-09-28T11:41:26Z | - |
dc.date.issued | 2020-05 | - |
dc.identifier.issn | 0937-941X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/179252 | - |
dc.description.abstract | The effect of anti-resorptive drug (ARD) usage among patients with successful dental implant osseointegration is controversial. This study showed an increased risk of implant failure in ARD users. Risk factors included pre-existing marginal bone loss, overdenture, diabetes, and a short interval between implant placement and ARD administration. Introduction: This retrospective study aimed to determine whether anti-resorptive drug (ARD) usage increased risk of implant failure among patients with successful implant osseointegration. Additionally, the study investigated risk factors that affected implant survival rate in ARD users. Methods: Eighty ARD users with 344 implants who had more than 12 months of follow-up from the initiation of ARD treatment during the period between 2008 and 2017 were included, along with 80 non-ARD users from the same period. The primary outcome was dental implant survival. Kaplan-Meier survival curves and Cox proportional hazard models were used for survival analysis. Results: Average follow-up was 85.3 months. Implant survival rates were 89.83% in ARD users and 96.03% in non-ARD users. In the univariate Cox proportional hazard model, risk of implant failure was significantly higher in patients with pre-existing marginal bone loss (MBL), diabetes, and concurrent bone augmentation. However, risk of implant failure was significantly lower when the interval between implant placement and ARD administration was < 36 months. Compared with overdenture, single crown and fixed splinted users had lower risk of implant failure. In multivariate analysis, variables including pre-existing MBL, diabetes, < 36-month interval between implant placement and ARD treatment, and usage of fixed splinted prosthesis were significantly associated with increased risk of implant failure. Conclusions: ARD administration after implant osseointegration was correlated with a reduced implant survival rate. Pre-existing MBL, diabetes, type of final prosthesis, and the interval between implant placement and initiation of ARD administration influenced risk of implant failure. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Springer International | - |
dc.relation.isPartOf | OSTEOPOROSIS INTERNATIONAL | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Effects of anti-resorptive drugs on implant survival and peri-implantitis in patients with existing osseointegrated dental implants: a retrospective cohort study | - |
dc.type | Article | - |
dc.contributor.college | College of Dentistry (치과대학) | - |
dc.contributor.department | Dept. of Oral and Maxillofacial Surgery (구강악안면외과학교실) | - |
dc.contributor.googleauthor | J Y Kim | - |
dc.contributor.googleauthor | H Choi | - |
dc.contributor.googleauthor | J H Park | - |
dc.contributor.googleauthor | H D Jung | - |
dc.contributor.googleauthor | Y S Jung | - |
dc.identifier.doi | 10.1007/s00198-019-05257-3 | - |
dc.contributor.localId | A05339 | - |
dc.contributor.localId | A05594 | - |
dc.contributor.localId | A03655 | - |
dc.contributor.localId | A03792 | - |
dc.relation.journalcode | J02451 | - |
dc.identifier.eissn | 1433-2965 | - |
dc.identifier.pmid | 32367226 | - |
dc.identifier.url | https://link.springer.com/article/10.1007%2Fs00198-019-05257-3 | - |
dc.subject.keyword | Anti-resorptives | - |
dc.subject.keyword | Dental biology | - |
dc.subject.keyword | Implants | - |
dc.subject.keyword | Osteoporosis | - |
dc.contributor.alternativeName | Park, Jin Hoo | - |
dc.contributor.affiliatedAuthor | 박진후 | - |
dc.contributor.affiliatedAuthor | 김준영 | - |
dc.contributor.affiliatedAuthor | 정영수 | - |
dc.contributor.affiliatedAuthor | 정휘동 | - |
dc.citation.volume | 31 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 1749 | - |
dc.citation.endPage | 1758 | - |
dc.identifier.bibliographicCitation | OSTEOPOROSIS INTERNATIONAL, Vol.31(9) : 1749-1758, 2020-05 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.